title: Alcohol withdrawal syndrome in medical patients.
abstract: The authors provide a critical review focusing on pharmacotherapy of alcohol withdrawal syndrome in hospitalized patients who are not critically ill. They outline recommendations for patient assessment and monitoring.
authors.affiliation: Assistant Professor, Director of Assessment, Division of Pharmacy, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA. E-mail: justine.gortney@wayne.edu.
authors.forename: Justine S
authors.initials: JS
authors.lastname: Gortney
authors.affiliation: Clinical Pharmacist Specialist in Internal Medicine, Assistant Program Director, Pharmacy Practice, Detroit Receiving Hospital, Detroit, MI, USA.
authors.forename: Joshua N
authors.initials: JN
authors.lastname: Raub
authors.affiliation: Assistant Professsor, Wayne State School of Medicine, Division of Geriatrics, University Health Center, Detroit Receiving Hospital, Detroit, MI, USA.
authors.forename: Pragnesh
authors.initials: P
authors.lastname: Patel
authors.affiliation: United Physicians, Detroit, MI, USA.
authors.forename: Lianne
authors.initials: L
authors.lastname: Kokoska
authors.affiliation: Clinical Pharmacist, Detroit Receiving Hospital, Detroit, MI, USA.
authors.forename: Mae
authors.initials: M
authors.lastname: Hannawa
authors.affiliation: Clinical Pharmacist Specialist in Internal Medicine, Harper University Hospital, Detroit, MI, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Argyris
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy*; D020270:Alcohol Withdrawal Seizures / Q000188:drug therapy*; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use*; D002492:Central Nervous System Depressants / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D011595:Psychomotor Agitation / Q000188:drug therapy*; D012720:Severity of Illness Index; D013577:Syndrome
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000319:Adrenergic beta-Antagonists; D018726:Anti-Dyskinesia Agents; D000927:Anticonvulsants; D001463:Barbiturates; D002492:Central Nervous System Depressants; D001569:Benzodiazepines; D000431:Ethanol; D006220:Haloperidol